AMO Data Being Assessed by FDA over Eye Infection Rates May 25, 2007 08:35
Due to the high incidence of use of the AMO Complete product in patients suffering from Acanthamoeba infections, this product is being studied to determine the link. The product has been pulled from the market.
Disclaimer: Pennsylvania ReNu Attorney Disclaimer: ReNu, MoistureLoc, MoisturePlus, or other legal information set forth in this site should not be construed to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Please contact a Pennsylvania AMO Recall Lawyer at our law firm for information regarding your particular case. This website is not intended to solicit clients outside the States of New Jersey and Pennsylvania.
